Abstract
Point-of-care tests for SARS-CoV-2 could enable rapid rule-in and/or rule-out of COVID-19, allowing rapid and accurate patient cohorting and potentially reducing the risk of nosocomial transmission. As COVID-19 begins to circulate with other more common respiratory viruses, there is a need for rapid diagnostics to help clinicians test for multiple potential causative organisms simultaneously.However, the different technologies available have strengths and weaknesses that must be understood to ensure that they are used to the benefit of the patient and healthcare system. Device performance is related to the deployed context, and the diagnostic characteristics may be affected by user experience.This practice review is written by members of the UK’s COVID-19 National Diagnostic Research and Evaluation programme. We discuss relative merits and test characteristics of various commercially available technologies. We do not advocate for any given test, and our coverage of commercially supplied tests is not intended to be exhaustive.
Funder
UK Research and Innovation
British Lung Foundation
National Institute for Health Research
Asthma UK
Subject
Critical Care and Intensive Care Medicine,General Medicine,Emergency Medicine
Reference49 articles.
1. World Health Organization,, World Health Organization . Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19), 2020.
2. Rapid nosocomial spread of SARS-CoV-2 in a French geriatric unit;Vanhems;Infect Control Hosp Epidemiol,2020
3. Diagnostics for SARS-CoV-2 infections;Kevadiya;Nat Mater,2021
4. Triage decision-making at the time of COVID-19 infection: the Piacenza strategy;Erika;Intern Emerg Med,2020
5. An adapted emergency department triage algorithm for the COVID‐19 pandemic;Wallace;J Am Coll Emerg Physicians Open,2020
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献